239 related articles for article (PubMed ID: 36620593)
21. Cost-effectiveness of pembrolizumab for the first-line treatment of patients with unresectable or metastatic MSI-H/dMMR colorectal cancer in the United States.
Aguiar-Ibáñez R; Hardern C; van Hees F; Lee D; Patel A; Chhabra N; Baluni G; Amonkar M; Lai Y; Xu R; Massaad R; Fogelman D
J Med Econ; 2022; 25(1):469-480. PubMed ID: 35184650
[TBL] [Abstract][Full Text] [Related]
22. Clinical actionability of triaging DNA mismatch repair deficient colorectal cancer from biopsy samples using deep learning.
Jiang W; Mei WJ; Xu SY; Ling YH; Li WR; Kuang JB; Li HS; Hui H; Li JB; Cai MY; Pan ZZ; Zhang HZ; Li L; Ding PR
EBioMedicine; 2022 Jul; 81():104120. PubMed ID: 35753152
[TBL] [Abstract][Full Text] [Related]
23. Mismatch repair-deficient colorectal cancer: a model of immunogenic and immune cell-rich tumor despite nonsignificant programmed cell death ligand-1 expression in tumor cells.
Le Flahec G; Badic B; Guibourg B; Doucet L; Bail JP; Marcorelles P; Schick U; Uguen A
Hum Pathol; 2018 Feb; 72():135-143. PubMed ID: 29208565
[TBL] [Abstract][Full Text] [Related]
24. DNA Mismatch Repair-Deficient Colorectal Carcinoma: Referral Rate for Genetic Cancer Risk Assessment in a Brazilian Cancer Center.
Gomes AAD; Macedo MP; Torrezan GT; Zenun GR; Aguiar S; Begnami MD; Carraro DM; Formiga MN
J Gastrointest Cancer; 2021 Sep; 52(3):997-1002. PubMed ID: 32974876
[TBL] [Abstract][Full Text] [Related]
25. Microsatellite instability testing and its role in the management of colorectal cancer.
Kawakami H; Zaanan A; Sinicrope FA
Curr Treat Options Oncol; 2015 Jul; 16(7):30. PubMed ID: 26031544
[TBL] [Abstract][Full Text] [Related]
26. Topoisomerase-1 and -2A gene copy numbers are elevated in mismatch repair-proficient colorectal cancers.
Sønderstrup IM; Nygård SB; Poulsen TS; Linnemann D; Stenvang J; Nielsen HJ; Bartek J; Brünner N; Nørgaard P; Riis L
Mol Oncol; 2015 Jun; 9(6):1207-17. PubMed ID: 25777966
[TBL] [Abstract][Full Text] [Related]
27. Consequences of testing for mismatch repair deficiency of colorectal cancer in clinical practice.
Leicher LW; Lammertink MHA; Offerman SR; Morreau H; de Jong MM; de Groot JWB; van Westreenen HL; Vasen HFA; de Vos Tot Nederveen Cappel WH
Scand J Gastroenterol; 2018 May; 53(5):632-636. PubMed ID: 29161904
[TBL] [Abstract][Full Text] [Related]
28. Identification of Comprehensive Biomarkers in Patients With Mismatch Repair-Deficient Colon Adenocarcinoma Based on Parallel Multiomics.
Li Z; Teng L; Pan Z; Yang Y; Zhu J; Wu X; Qian Y; Qian H; Bian Y; Chen Y; Chen W; Bi L
Lab Invest; 2024 Feb; 104(2):100306. PubMed ID: 38104864
[TBL] [Abstract][Full Text] [Related]
29. Comparison of immunological characteristics between paired mismatch repair-proficient and -deficient colorectal cancer patients.
Liu SS; Yang YZ; Jiang C; Quan Q; Xie QK; Wang XP; He WZ; Rong YM; Chen P; Yang Q; Yang L; Zhang B; Xia XJ; Kong PF; Xia LP
J Transl Med; 2018 Jul; 16(1):195. PubMed ID: 30005666
[TBL] [Abstract][Full Text] [Related]
30. Tumor microenvironment classification based on T-cell infiltration and PD-L1 in patients with mismatch repair-proficient and -deficient colorectal cancer.
Liu S; Kong P; Wang X; Yang L; Jiang C; He W; Quan Q; Huang J; Xie Q; Xia X; Zhang B; Xia L
Oncol Lett; 2019 Feb; 17(2):2335-2343. PubMed ID: 30675299
[TBL] [Abstract][Full Text] [Related]
31. Deficient mismatch repair system in patients with sporadic advanced colorectal cancer.
Koopman M; Kortman GA; Mekenkamp L; Ligtenberg MJ; Hoogerbrugge N; Antonini NF; Punt CJ; van Krieken JH
Br J Cancer; 2009 Jan; 100(2):266-73. PubMed ID: 19165197
[TBL] [Abstract][Full Text] [Related]
32. Loss of survival advantage for deficient mismatch repair in patients with advanced colorectal cancer may be caused by changes in prognostic value of CD8+T cell.
Wang B; Li F; Guo L; Lu S; Ma J; Ma Y; Meng Y; Wang J; Zhou X; Fu W
World J Surg Oncol; 2020 Aug; 18(1):196. PubMed ID: 32767974
[TBL] [Abstract][Full Text] [Related]
33. Mismatch repair deficiency concordance between primary colorectal cancer and corresponding metastasis.
Haraldsdottir S; Roth R; Pearlman R; Hampel H; Arnold CA; Frankel WL
Fam Cancer; 2016 Apr; 15(2):253-60. PubMed ID: 26666765
[TBL] [Abstract][Full Text] [Related]
34. Development and validation of a radiomics-based nomogram for the preoperative prediction of microsatellite instability in colorectal cancer.
Ying M; Pan J; Lu G; Zhou S; Fu J; Wang Q; Wang L; Hu B; Wei Y; Shen J
BMC Cancer; 2022 May; 22(1):524. PubMed ID: 35534797
[TBL] [Abstract][Full Text] [Related]
35. Predicting Colorectal Cancer Survival Using Time-to-Event Machine Learning: Retrospective Cohort Study.
Yang X; Qiu H; Wang L; Wang X
J Med Internet Res; 2023 Oct; 25():e44417. PubMed ID: 37883174
[TBL] [Abstract][Full Text] [Related]
36. A Novel Prognostic Model and Practical Nomogram for Predicting the Outcomes of Colorectal Cancer: Based on Tumor Biomarkers and Log Odds of Positive Lymph Node Scheme.
Zhu J; Hao J; Ma Q; Shi T; Wang S; Yan J; Chen R; Xu D; Jiang Y; Zhang J; Li J
Front Oncol; 2021; 11():661040. PubMed ID: 33937076
[TBL] [Abstract][Full Text] [Related]
37. Systemic Inflammatory Markers of Resectable Colorectal Cancer Patients with Different Mismatch Repair Gene Status.
Li J; Zhang Y; Xu Q; Wang G; Jiang L; Wei Q; Luo C; Chen L; Ying J
Cancer Manag Res; 2021; 13():2925-2935. PubMed ID: 33833576
[TBL] [Abstract][Full Text] [Related]
38. Impact of mismatch repair or microsatellite status on the prognosis and efficacy to chemotherapy in metastatic colorectal cancer patients: A bi-institutional, propensity score-matched study.
Yao YC; Jin Y; Lei XF; Wang ZX; Zhang DS; Wang FH; Li YH; Xu RH; Wang F
J Cancer; 2022; 13(9):2912-2921. PubMed ID: 35912009
[No Abstract] [Full Text] [Related]
39. Association of Peripheral Blood Biomarkers With Response to Anti-PD-1 Immunotherapy for Patients With Deficient Mismatch Repair Metastatic Colorectal Cancer: A Multicenter Cohort Study.
Cheng YK; Chen DW; Chen P; He X; Li PS; Lin ZS; Chen SX; Ye SB; Lan P
Front Immunol; 2022; 13():809971. PubMed ID: 35185898
[TBL] [Abstract][Full Text] [Related]
40. DNA mismatch repair deficiency and hereditary syndromes in Latino patients with colorectal cancer.
Ricker CN; Hanna DL; Peng C; Nguyen NT; Stern MC; Schmit SL; Idos GE; Patel R; Tsai S; Ramirez V; Lin S; Shamasunadara V; Barzi A; Lenz HJ; Figueiredo JC
Cancer; 2017 Oct; 123(19):3732-3743. PubMed ID: 28640387
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
